Exact FDA event identifier

Event 72028

13 recalled-product records grouped only because every row carries this exact official event ID.

Event summary

Timeline bucket: August 21, 2015
Product types: Drug
Classifications: Class I and Class II
Statuses: Terminated
Recalling firm wording: Cantrell Drug Company

Dossier provenance

Source snapshots represented here

openFDA Drug Enforcement Report-date coverage June 20, 2012–July 08, 2026 Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.

Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.

How coverage and grouping work

Device root-cause evidence is not applicable to this event. No grouped product has the official product type device; this is not an unavailable-enrichment finding.

Complete imported group

Every recalled product in this event

13 official enforcement rows

Product dates, classifications, firms, and source wording remain attached to their individual rows. Opening this dossier never hides products that did not match a prior timeline filter.

drug · product 1 of 13

fentaNYL citrate in 0.9% Sodium Chloride Injection, 10 mcg/1 mL (10 mcg/mL), in 1 mL Syringe, Rx Only, Cantrell Drug Co., Little Rock, AR --- NDC 52533-024-45, UPC: 0100352533024450

D-1152-2016

Recall number: D-1152-2016
Initiated: August 21, 2015
Classification: Class I
Status: Terminated
Recalling firm: Cantrell Drug Company
Quantity: 884 syringes

App-derived interpretation

Potency or specification failure reason.potency_specification_failure · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Subpotent Drug

Code information

Lot: 6234, exp 9/20/15

Distribution pattern

Nationwide

drug · product 2 of 13

Atropine Sulfate Injection Solution, 0.4 mg/1 mL (0.4 mg/mL), in a) 1 mL syringes and b) 2 mL syringes, Rx Only, Cantrell Drug Co., Little Rock, AR --- NDC 52533-010-45, UPC: 0100352533010453

D-1153-2016

Recall number: D-1153-2016
Initiated: August 21, 2015
Classification: Class I
Status: Terminated
Recalling firm: Cantrell Drug Company
Quantity: a) 450 syringes and b) 1250 syringes

App-derived interpretation

Potency or specification failure reason.potency_specification_failure · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Subpotent Drug

Code information

a) Lots: 149690, exp 9/14/15 and 151665, exp 11/5/15 and b) Lots: 149198, exp 9/3/15; 151454, exp 9/14/15; 151668, exp 11/5/15 and 151962, exp 11/11/15

Distribution pattern

Nationwide

drug · product 3 of 13

fentaNYL Citrate 1 MCG/mL in 0.9% Sodium Chloride Injection, in 3 mL Syringe, Rx Only, Cantrell Drug Co., Little Rock, AR --- UPC: 9999992131

D-1154-2016

Recall number: D-1154-2016
Initiated: August 21, 2015
Classification: Class I
Status: Terminated
Recalling firm: Cantrell Drug Company
Quantity: 42 syringes

App-derived interpretation

Potency or specification failure reason.potency_specification_failure · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Subpotent Drug

Code information

Lot: 150125, 12/19/15

Distribution pattern

Nationwide

drug · product 4 of 13

fentaNYL CITRATE 25 mcg/mL in 5% DEXTROSE Injection, in 2 mL Syringe, Rx Only, Cantrell Drug Co., Little Rock AR --- UPC: 9999993301

D-1155-2016

Recall number: D-1155-2016
Initiated: August 21, 2015
Classification: Class I
Status: Terminated
Recalling firm: Cantrell Drug Company
Quantity: 235 syringes

App-derived interpretation

Potency or specification failure reason.potency_specification_failure · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Subpotent Drug

Code information

Lot: 151142, exp 10/22/15

Distribution pattern

Nationwide

drug · product 5 of 13

fentaNYL citrate in 0.9% Sodium Chloride Injection, 5 mcg/1 mL (5 mcg/mL), in a) 1 mL syringe (NDC 52533-214-45, UPC: 0100352533214455) and b) 3 mL syringe (NDC 52533-214-60, UPC: 0100352533214608), Rx Only, Cantrell Drug Co., Little Rock, AR

D-1156-2016

Recall number: D-1156-2016
Initiated: August 21, 2015
Classification: Class I
Status: Terminated
Recalling firm: Cantrell Drug Company
Quantity: a) 564 syringes and b) 1146 syringes

App-derived interpretation

Potency or specification failure reason.potency_specification_failure · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Subpotent Drug

Code information

a) Lots: 148292, exp 11/9/15 and 150610, exp 1/6/16 and b) Lots: 6208, exp 9/16/15 and 6851, exp 1/19/16

Distribution pattern

Nationwide

drug · product 6 of 13

fentaNYL CITRATE 4 MCG/mL in 0.9% SODIUM CHLORIDE Injection, in 1 mL Syringe, Rx Only, Cantrell Drug Co., Little Rock, AR --- UPC: 9999993491

D-1157-2016

Recall number: D-1157-2016
Initiated: August 21, 2015
Classification: Class I
Status: Terminated
Recalling firm: Cantrell Drug Company
Quantity: 148 syringes

App-derived interpretation

Potency or specification failure reason.potency_specification_failure · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Subpotent Drug

Code information

Lot: 150370, exp 1/2/16

Distribution pattern

Nationwide

drug · product 7 of 13

fentaNYL Citrate 50 mcg/mL in Sterile Water for Injection, packaged in 2 mL syringe, Rx Only, Cantrell Drug Co., Little Rock, AR --- NDC 52533-074-16, UPC: 0100352533074165

D-1158-2016

Recall number: D-1158-2016
Initiated: August 21, 2015
Classification: Class I
Status: Terminated
Recalling firm: Cantrell Drug Company
Quantity: 1652 syringes

App-derived interpretation

Potency or specification failure reason.potency_specification_failure · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Subpotent Drug

Code information

Lot: 6324, exp 10/11/15

Distribution pattern

Nationwide

drug · product 8 of 13

HEParin Sodium 0.5 USP UNITS/mL in 0.225% SODIUM CHLORIDE, in 3 mL Syringe, Rx Only, Cantrell Drug Co., Little Rock, AR --- UPC: 9999992212

D-1159-2016

Recall number: D-1159-2016
Initiated: August 21, 2015
Classification: Class II
Status: Terminated
Recalling firm: Cantrell Drug Company
Quantity: 352 syringes

App-derived interpretation

Potency or specification failure reason.potency_specification_failure · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Stability Data Does Not Support Expiry

Code information

Lot: 150090, exp 12/24/15

Distribution pattern

Nationwide

drug · product 9 of 13

HEPARIN Sodium in 0.45% Sodium Chloride, 1 USP Unit/2 mL (0.5 USP Units/mL), Rx Only, Cantrell Drug Co., Little Rock, AR --- NDC 52533-148-16, UPC: 0100352533148163

D-1160-2016

Recall number: D-1160-2016
Initiated: August 21, 2015
Classification: Class II
Status: Terminated
Recalling firm: Cantrell Drug Company
Quantity: 4170 syringes

App-derived interpretation

Potency or specification failure reason.potency_specification_failure · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Stability Data Does Not Support Expiry

Code information

Lot: 6146, exp 9/5/15

Distribution pattern

Nationwide

drug · product 10 of 13

LIDocaine HCl 1% BUFFERED WITH SODIUM BICARBONATE Injection, packaged in 3 mL Syringes, Rx Only, Cantrell Drug Co., Little Rock, AR --- UPC: 9999992033

D-1161-2016

Recall number: D-1161-2016
Initiated: August 21, 2015
Classification: Class II
Status: Terminated
Recalling firm: Cantrell Drug Company
Quantity: 450 syringes

App-derived interpretation

Potency or specification failure reason.potency_specification_failure · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Subpotent Drug

Code information

Lot: 150947, exp 9/5/15; 151087, exp 9/21/15

Distribution pattern

Nationwide

drug · product 11 of 13

Midazolam HCl in 0.9% Sodium Chloride Injection, 0.5 mg/mL 1 mL (0.5 mg/mL), 1 mL syringes, Rx Only, Cantrell Drug Co., Little Rock AR --- NDC 52533-157-45, UPC: 0100352533157455

D-1162-2016

Recall number: D-1162-2016
Initiated: August 21, 2015
Classification: Class II
Status: Terminated
Recalling firm: Cantrell Drug Company
Quantity: 3853 syringes

App-derived interpretation

Potency or specification failure reason.potency_specification_failure · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Subpotent Drug

Code information

Lot: 6218, exp 9/17/15; 6877, exp 1/24/16

Distribution pattern

Nationwide

drug · product 12 of 13

MIDAZolam HCl 0.1 mg/mL in 5% DEXTROSE 2.5 mL syringe, Rx Only, Cantrell Drug Co., Little Rock, AR --- UPC: 9999993721

D-1163-2016

Recall number: D-1163-2016
Initiated: August 21, 2015
Classification: Class II
Status: Terminated
Recalling firm: Cantrell Drug Company
Quantity: 212 syringes

App-derived interpretation

Potency or specification failure reason.potency_specification_failure · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Subpotent Drug

Code information

Lot: 149167, exp 9/2/15

Distribution pattern

Nationwide

drug · product 13 of 13

MIDAZOLAM HCl in 0.9% Sodium Chloride Injection, 2 mg/2 mL (1 mg/mL), in 2 mL syringe, Rx only, Cantrell Drug Co., Little Rock, AR --- NDC 52533-001-16 UPC: 0100352533001161

D-1164-2016

Recall number: D-1164-2016
Initiated: August 21, 2015
Classification: Class II
Status: Terminated
Recalling firm: Cantrell Drug Company
Quantity: 1570 syringes

App-derived interpretation

Potency or specification failure reason.potency_specification_failure · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Subpotent Drug

Code information

Lot: 6178, exp, 9/12/15; 6529, exp 11/22/15

Distribution pattern

Nationwide